Ignite Creation Date:
2025-12-24 @ 4:32 PM
Ignite Modification Date:
2025-12-24 @ 4:32 PM
Study NCT ID:
NCT06790966
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-12-11
First Post:
2025-01-14
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Phase 3 Study of PDS0101 and Pembrolizumab in HPV16+ Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
Sponsor:
PDS Biotechnology Corp.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-05-30
Start Date Type:
ACTUAL
Primary Completion Date:
2029-02
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-02
Completion Date Type:
ESTIMATED
First Submit Date:
2025-01-14
First Submit QC Date:
None
Study First Post Date:
2025-01-24
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-10
Last Update Post Date:
2025-12-11
Last Update Post Date Type:
ESTIMATED